Zobrazeno 1 - 10
of 162
pro vyhledávání: '"AIDSVAX"'
Autor:
De Cock, Kevin M., author
Publikováno v:
Dispatches from the AIDS Pandemic : A Public Health Story, 2023.
Externí odkaz:
https://doi.org/10.1093/oso/9780197626528.003.0016
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Philip Kotze, Fatima Laher, Mary Allen, Peter B. Gilbert, Jia J. Kee, Dishiki Jenny Kalonji, Carter Bentley, Susan W. Barnett, Tricia Philip, Craig Innes, Adrian Puren, Holly Janes, Millicent Atujuna, Nivashnee Naicker, M. Juliana McElrath, Philisiwe B. Makhoba, Gladys Kobane, Girisha Kistnasami, Katlego S. Mapetla, Zakir Gaffoor, Cleon N. Ncayiya, Sanjay Phogat, Vimla Naicker, Simbarashe Takuva, James G. Kublin, Linda-Gail Bekker, Nima S. Hejazi, David Benkeser, Niranjan Kanesa-thasan, Modulakgotla Sebe, Olivier Van Der Meeren, Yunda Huang, Bontle Modibedi, Pamela Mda, Mookho Malahleha, Mpho Sikhosana, Matsontso Mathebula, Pearl Selepe, Amy Ward, Lawrence Corey, Megan Jones, John Hural, Tania Adonis, Sheetal Kassim, Carlos Diaz Granados, Nicole Grunenberg, Shelly Ramirez, Doug Grove, Maphoshane Nchabeleng, Brittany Prigmore, Graeme Meintjes, Erica Lazarus, William Brumskine, Lubbe Wiesner, Nigel Garrett, Marguerite Koutsoukos, Thozama Dubula, Zoe Moodie, Glenda Gray, Nishanta Singh, Michele P. Andrasik
Publikováno v:
The New England journal of medicine. 384(12)
Background A safe, effective vaccine is essential to eradicating human immunodeficiency virus (HIV) infection. A canarypox-protein HIV vaccine regimen (ALVAC-HIV plus AIDSVAX B/E) showed modest efficacy in reducing infection in Thailand. An analogous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fbe0fad196305adb7e7bbb1cc0f70e1
https://pubmed.ncbi.nlm.nih.gov/33761212
https://pubmed.ncbi.nlm.nih.gov/33761212
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Maurine D. Miner, Lindsey R. Baden, Colleen F. Kelley, M. Juliana McElrath, Martin Casapia, Kelly E. Seaton, Georgia D. Tomaras, Paul A. Goepfert, Susan Buchbinder, Janine Maenza, Michael C. Keefer, Magdalena E. Sobieszczyk, Javier R. Lama, Stephen C. De Rosa, Faruk Sinangil, Carter Lee, Harriet L. Robinson, David C. Montefiori, Vineeta Gulati, Marnie Elizaga, Carmen Paez, Chenchen Yu, Kristen W. Cohen, Laura Polakowski, Yunda Huang
Publikováno v:
Vaccine
Background Eliciting durable humoral immunity with sufficient breadth and magnitude is important for HIV-1 vaccine design. The HVTN 114 vaccine trial evaluated different boost regimens administered after a 7-year rest period in participants previousl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb1f11b109ac04abb578782749b0f1d9
https://pubmed.ncbi.nlm.nih.gov/34229888
https://pubmed.ncbi.nlm.nih.gov/34229888
Autor:
M. Anthony Moody, Marzena Pazgier, Sherry Stanfield-Oakley, Barton F. Haynes, Mattia Bonsignori, George K. Lewis, David Easterhoff, Rebekah Sherburn, Krishanu Ray, William D. Tolbert, Guido Ferrari, Dung N. Nguyen, Marina Tuyishime, Verna Van, Fang Yan
Publikováno v:
mBio
mBio, Vol 11, Iss 3 (2020)
mBio, Vol 11, Iss 3, p e00208-20 (2020)
mBio, Vol 11, Iss 3 (2020)
mBio, Vol 11, Iss 3, p e00208-20 (2020)
Antibody-dependent cellular cytotoxicity (ADCC) correlated with a reduced risk of infection from HIV-1 in the RV144 vaccine trial, the only HIV-1 vaccine trial to date to show any efficacy. Antibodies specific for CD4-induced envelope (Env) epitopes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3b5349a2d42b74a61d4a9e29a0bb3d2
http://europepmc.org/articles/PMC7327165
http://europepmc.org/articles/PMC7327165
Autor:
James J. Kobie, Madhubanti Basu, Christopher F. Fucile, Alexander F. Rosenberg, Jane L. Liesveld, Fritzlaine C. Roche, Michael C. Keefer, Michael S. Piepenbrink, Catherine A. Bunce, Bo Zheng, Ann J. Hessell, David A. Spencer, Czestochowa Francois
Publikováno v:
Cell Reports Medicine, Vol 1, Iss 2, Pp 100015-(2020)
Cell reports medicine
Cell reports medicine
SUMMARY Induction of persistent HIV-1 Envelope (Env) specific antibody (Ab) is a primary goal of HIV vaccine strategies; however, it is unclear whether HIV Env immunization in humans induces bone marrow plasma cells, the presumed source of long-lived
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce35f027550b58529a94a0cc0a408f9c
http://www.sciencedirect.com/science/article/pii/S2666379120300203
http://www.sciencedirect.com/science/article/pii/S2666379120300203
Autor:
Piyathida Sroysuwan, Natthapol Kosashunhanan, Sebastian Molnar, Jerome H. Kim, Alexandra Schuetz, Taweewat Supindham, Elizabeth Heger, Sandhya Vasan, Phiromrat Rakyat, Suwat Chariyalertsak, Nittaya Phanuphak, Siriluck Teerachia, Suchada Chinaworapong, Nongluck Sangnoi, Oranitcha Kaewthip, Sorachai Nitayaphan, Surat Jongrakthaitae, Pornchanok Panjapornsuk, Michael A. Eller, Puttachard Saengtawan, Weerawan Chuenarom, Nuntisa Chotirosniramit, Pornsuk V. Grandin, Sirinan Madnote, Benjaluck Phonrat, Rungsun Rerknimitr, Narongrid Sirisopana, Lindsay Wieczorek, Siriwat Akapirat, Chirapa Eamsila, Faruk Sinangil, Kirsten Smith, James Tartaglia, Poonam Pegu, Dohoon Kim, Carter Lee, Peter Dawson, Saowanit Getchalarat, Robert J. O'Connell, Nicos Karasavvas, Jiraporn Puangkaew, Patcharaphan Sugandhavesa, Nitiya Chomchey, Punnee Pitisuttithum, Jean-Louis Excler, Boonlure Pruenglampoo, Yingjun Zhou, Yupa Sabmee, Jittima Dhitavat, Merlin L. Robb, Jesse Schoen, Victoria R. Polonis, Nelson L. Michael, Boot Kaewboon, Nipat Teeratakulpisarn, Bessara Nuntapinit, Wanlaya Labwech, Eugene Kroon, Viseth Ngauy, Prapaporn Savaraj, Jaranit Kaewkungwal, Pawinee Jarujareet, Nampueng Churikanont, Surawach Rittiroongrad, Somsak Chantakulkij, Anant Phramtong, Rapee Trichavaroj, Carlos A. DiazGranados, Silvia Ratto-Kim, Sanjay Phogat, Mark de Souza, Arom Pitisuthitham, Nipattra Tragonlugsana
Publikováno v:
Lancet HIV
BACKGROUND: The RV144 phase 3 vaccine trial in Thailand demonstrated that ALVAC-HIV (vCP1521) and AIDSVAX® B/E administration over six months resulted in a 31% efficacy in preventing HIV acquisition. In this trial, we assessed the immunologic impact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85f962459539bb0b1f931c1b9f15f516
https://europepmc.org/articles/PMC7247755/
https://europepmc.org/articles/PMC7247755/
